www.aciont.com Open in urlscan Pro
2606:4700::6811:c449  Public Scan

Form analysis
0 forms found in the DOM

Text Content

REDEFINING NONINVASIVE 


OCULAR THERAPEUTICS

Toggle Navigation
 * Home
 * About Us
 * Technologies
 * Product Pipeline
 * News
 * Contact

 * Home
 * About Us
 * Technologies
 * Product Pipeline
 * News
 * Contact

Aciont Inc. is a mid-clinical staged, specialty biopharmaceutical company
located in Salt Lake City, Utah.  Our Visulex noninvasive drug delivery
technology platforms endeavor to advance therapeutics in ophthalmology.  Our
world renowned research team is focused on developing noninvasive therapeutics
for sight threatening diseases of both the anterior and posterior sections of
the eye addressing a potential wide range of ocular diseases requiring therapies
with drug transport and controlled release challenges.   Our lead clinical
staged product, DSP Visulex, addresses key ocular inflammation related
indications such as severe uveitis, post operative pain/inflammation and macular
edema.   


LATEST NEWS

See the latest news and corporate updates.

LEADERSHIP

Review our mission statement and profiles of Aciont's leadership and advisory
team.

PUBLICATIONS AND RESEARCH

See references to relevant peer reviewed publications and research materials.

MEETINGS AND PRESENTATIONS

See where Aciont will be presenting in the near future.   用中文（表达

INVESTORS AND PARTNERING

Please contact us if you share an interest in our mission to advance ocular
therapeutics.   

 * Home
 * About Us
 * Technologies
 * Product Pipeline
 * News
 * Contact

© 2018 Aciont Inc.

/



ZurückWeiter
PauseAbspielenSchließen